Figure 5

BARX2 expression and clinical features in LIHC patients in the TCGA dataset. (A) Comparison of BARX2 expression levels between normal subjects and LIHC patients by UALCAN analysis. (B) Effect of T stage on the expression level of BARX2 in LIHC patients. (C) Effect of residual tumour on the expression level of BARX2 in LIHC patients.